[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lexeo Therapeutics Inc (LXEO)

Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Lexeo Therapeutics Reports Monday With Insiders Already Reducing Stakes

Lexeo Therapeutics (NASDAQ: LXEO) reports first-quarter 2026 earnings on Sunday, May 11, before the market opens, with analysts forecasting a loss of $0.29 per share. The central question for investors: can the clinical-stage gene therapy company sustain the momentum from three consecutive earnings beats while managing cash burn and advancing its pipeline? With the stock trading well below analyst price targets and technical indicators flashing caution, this report will test whether recent operational improvements can offset broader concerns about the company's path to profitability.

Lexeo Therapeutics is a clinical-stage biotechnology company developing gene therapies for cardiovascular and central nervous system disorders, with lead...

Fundamentals

See More
  • Market Capitalization, $K 457,777
  • Shares Outstanding, K 78,521
  • Annual Sales, $ 0 K
  • Annual Income, $ -99,960 K
  • EBIT $ -109 M
  • EBITDA $ -109 M
  • 60-Month Beta 1.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 373.05% (+151.95%)
  • Historical Volatility 66.34%
  • IV Percentile 77%
  • IV Rank 29.94%
  • IV High 1,059.77% on 03/24/26
  • IV Low 79.58% on 08/18/25
  • Expected Move (DTE 5) 0.24 (4.08%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 16
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 1,307
  • Open Int (30-Day) 1,313
  • Expected Range 5.59 to 6.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.29
  • Number of Estimates 5
  • High Estimate $-0.26
  • Low Estimate $-0.34
  • Prior Year $-0.99
  • Growth Rate Est. (year over year) +70.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.54 +5.23%
on 05/01/26
7.01 -16.89%
on 04/17/26
-0.61 (-9.47%)
since 04/08/26
3-Month
5.01 +16.37%
on 03/30/26
8.00 -27.13%
on 03/09/26
-1.33 (-18.58%)
since 02/06/26
52-Week
2.43 +139.92%
on 05/15/25
10.99 -46.95%
on 12/23/25
+2.83 (+94.33%)
since 05/08/25

Most Recent Stories

More News
Lexeo Therapeutics Reports Monday With Insiders Already Reducing Stakes

Barchart Research What to Expect from LXEO Earnings LXEO Generated May 8, 2026 Current Price $5.83 EPS Estimate $$-0.29 Consensus Rating Strong Buy Average Move 8.80% Lexeo Therapeutics Reports Monday...

LXEO : 5.83 (+0.17%)
Lexeo Therapeutics Reports Monday With Insiders Already Reducing Stakes

Barchart Research What to Expect from LXEO Earnings LXEO Generated May 8, 2026 Current Price $5.83 EPS Estimate $$-0.29 Consensus Rating Strong Buy Average Move 8.80% Lexeo Therapeutics Reports Monday...

LXEO : 5.83 (+0.17%)
Lexeo Therapeutics Reports Monday With Insiders Already Reducing Stakes

Barchart Research What to Expect from LXEO Earnings LXEO Generated May 8, 2026 Current Price $5.83 EPS Estimate $$-0.29 Consensus Rating Strong Buy Average Move 8.80% Lexeo Therapeutics Reports Monday...

LXEO : 5.83 (+0.17%)
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced...

LXEO : 5.83 (+0.17%)
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 submitted to FDA in Q1 2026 following Type B meeting; study initiation on track for 1H 2026 First CMC Development and Readiness...

LXEO : 5.83 (+0.17%)
LXEO's Cardiac Gene Therapy Data Finally Arrives: The Pivot Wall Street Demanded or Another Clinical Stall?

Barchart Research What to Expect from LXEO Earnings LXEO Generated March 28, 2026 Current Price $5.46 EPS Estimate $-0.32 Consensus Rating Strong Buy Average Move 8.90% LXEO's Cardiac Gene Therapy Data...

LXEO : 5.83 (+0.17%)
LXEO's Cardiac Gene Therapy Data Finally Arrives: The Pivot Wall Street Demanded or Another Clinical Stall?

Barchart Research What to Expect from LXEO Earnings LXEO Generated March 28, 2026 Current Price $5.46 EPS Estimate $-0.32 Consensus Rating Strong Buy Average Move 8.90% LXEO's Cardiac Gene Therapy Data...

LXEO : 5.83 (+0.17%)
Payroll Figures Due in Canada Next Week

Monday Economic Lookahead Construction spending (delayed report) (Jan.) Featured Earnings ...

CNM : 49.09 (-1.15%)
HUMA : 1.0600 (-1.85%)
CNTA : 39.59 (-0.05%)
AIR : 117.78 (-0.03%)
IMMX : 9.75 (+2.20%)
SA : 31.21 (+5.05%)
CDZI : 4.75 (-0.84%)
SFD : 25.95 (-0.50%)
AGX : 680.26 (-1.41%)
LXEO : 5.83 (+0.17%)
PAYX : 93.93 (-0.35%)
SBC : 3.18 (-0.93%)
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases,...

LXEO : 5.83 (+0.17%)
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases,...

LXEO : 5.83 (+0.17%)

Business Summary

Lexeo Therapeutics is a clinical-stage genetic medicine company which defined cardiovascular diseases and APOE4-associated Alzheimer's disease are treated. Lexeo Therapeutics is based in New York City.

See More

Key Turning Points

3rd Resistance Point 6.27
2nd Resistance Point 6.11
1st Resistance Point 5.97
Last Price 5.83
1st Support Level 5.68
2nd Support Level 5.52
3rd Support Level 5.38

See More

52-Week High 10.99
Fibonacci 61.8% 7.72
Fibonacci 50% 6.71
Last Price 5.83
Fibonacci 38.2% 5.70
52-Week Low 2.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.